日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic analysis of patients with CRLM based on CRS score: a single-center retrospective study

基于CRS评分的结直肠癌肝转移患者预后分析:一项单中心回顾性研究

Xue, Jun-Shuai; Maimaitiming, Nuersimanguli; Zhang, Bo-Lun; Xu, Bo-Wen; Yin, Xin; Huang, Zhen; Che, Xu; Zhao, Hong; Cai, Jian-Qiang

Brain organoids: A new tool for modelling of neurodevelopmental disorders

脑类器官:一种用于模拟神经发育障碍的新工具

Aili, Yirizhati; Maimaitiming, Nuersimanguli; Wang, Zengliang; Wang, Yongxin

Tumor microenvironment and exosomes in brain metastasis: Molecular mechanisms and clinical application

脑转移瘤的肿瘤微环境和外泌体:分子机制和临床应用

Aili, Yirizhati; Maimaitiming, Nuersimanguli; Qin, Hu; Ji, Wenyu; Fan, Guofeng; Wang, Zengliang; Wang, Yongxin

Identification of VASH1 as a Potential Prognostic Biomarker of Lower-Grade Glioma by Quantitative Proteomics and Experimental Verification

通过定量蛋白质组学和实验验证鉴定VASH1作为低级别胶质瘤的潜在预后生物标志物

Yirizhati Aili, Nuersimanguli Maimaitiming, Aierpati Maimaiti, Wen Liu, Hu Qin, Wenyu Ji, Yusufu Mahemuti, Yongxin Wang, Zengliang Wang

Computational Drug Repurposing Approach to Identify Novel Inhibitors of ILK Protein for Treatment of Esophageal Squamous Cell Carcinoma

计算药物再利用方法识别用于治疗食管鳞状细胞癌的新型 ILK 蛋白抑制剂

Juan Liu, Xiaoli Ma, Leiyu Cao, Yu Wei, Yan Gao, Chengcheng Qu, Nuersimanguli Maimaitiming, Li Zhang

The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma

RPL4P4假基因是一种预后生物标志物,与胶质瘤的免疫浸润相关。

Wang, Zengliang; Aili, Yirizhati; Wang, Yongxin; Maimaitiming, Nuersimanguli; Qin, Hu; Ji, Wenyu; Fan, Guofeng; Li, Bo

Evaluation of the application value of a three-dimensional digital model of the knee in clinical practice

评估膝关节三维数字模型在临床实践中的应用价值

Keremu, Ajimu; Mijiti, Nuersimanguli; Mijiti, Sirejiding; Tuxun, Aikebaier; Abudurexiti, Abulikemu